-+ 0.00%
-+ 0.00%
-+ 0.00%

Nanjing Leads Biolabs Chairman Plans Share Purchases of Up to HK$ 20 Million

PUBT·11/19/2026 23:05:05
Listen to the news
Nanjing Leads Biolabs Chairman Plans Share Purchases of Up to HK$ 20 Million
  • Nanjing Leads Biolabs Chairman and CEO Kang Xiaoqiang plans open-market H share purchases totaling up to HK$20 million.
  • Purchases are planned over approximately six months, using his own or his close associates' funds.
  • Kang currently holds interests in 29,500,320 H Shares, representing 14.92% of issued H Shares and 14.83% of total issued share capital.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nanjing Leads Biolabs Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261120-12419357), on November 19, 2026, and is solely responsible for the information contained therein.